Skip to Content
🌐Ship toSelect country

Juvederm Voluma Lidocaine - 2 x 1,0ml

Juvéderm Voluma XC uses Vycross technology at 20 mg/ml hyaluronic acid with 0.3% lidocaine, formulated as a dense, highly cohesive gel for deep structural support. It is FDA- and CE-indicated for deep injection to correct age-related volume loss in the cheeks, to augment the chin profile, and to improve moderate to severe temple hollowing, in adults over 21. Its high cohesivity allows it to hold shape under muscle movement, making it a primary choice for midface volumising. Clinically reported duration is up to around 18 months with optimal treatment. For use by licensed, trained medical practitioners only.

198.00 € 198.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand JUVÉDERM®
SKU A0101 Share
Treatment Areas CheeksChinFace
Tags Cross-Linked Hyaluronic AcidFDA-ApprovedHyaluronic AcidLidocaineVolumizer

Juvederm Voluma is the firmest, most structurally supportive filler in Allergan's VYCROSS collection, engineered at a high hyaluronic acid concentration (20mg/ml) specifically for deep injection into the cheeks, chin and temples. Its cross-linked gel is designed to correct age-related volume loss and restore facial contour with strong lifting capacity, and it holds FDA approval for cheek, chin and temple augmentation in adults.

As with the rest of the VYCROSS range, Voluma is pre-mixed with lidocaine for injection comfort and can be reversed with hyaluronidase if adjustment is required. Clinical studies have shown results lasting up to two years in the cheek area.

CONCENTRATION

  • Hyaluronic acid 20mg/ml (VYCROSS technology)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.0ml Syringes
  • Sterile needles

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

FDA-approved for cheek, chin and temple augmentation in adults over 21; results reported to last up to 2 years in the cheek area.

INDICATIONS

  • Age-related volume loss in the mid-face
  • Chin and temple augmentation

TREATMENT AREAS

  • Cheeks
  • Chin
  • Temples

Juvederm Voluma is injected into the deep subcutaneous or supraperiosteal plane using a 27G½" needle or 25G1" needle/cannula, applying even pressure while slowly moving the needle. Injection may be antegrade or retrograde.

A review appointment is typically scheduled after 2-4 weeks to assess final results; touch-up implantation may be needed.

  • Severe allergies (history of anaphylaxis or multiple severe allergies)
  • Known hypersensitivity to gram-positive bacterial proteins or lidocaine
  • Do not inject into blood vessels — may cause embolisation, vessel occlusion, ischaemia or infarction
  • History of excessive/hypertrophic scarring or pigmentation disorders (not studied)
  • Pregnancy, breastfeeding, or patients under 21